0950.HK Lee's Pharmaceutical Factory Fundamental Research and Analysis Report
(0950.HK) Lee’s Pharmaceutical’s current price is HK$1.20. The medium- to long-term price trend (weekly MA10) is bullish, with the weekly chart showing a volatile structure this period. The near-term price trend (daily MA10) is also bullish, and the daily chart is currently in an upward formation. The medium- to long-term price trend of the Hang Seng Index (weekly K-line MA10) is bearish. Strong operations, undervalued. The core metric of operating cash flow to net profit is 2.47 for the current period, down 10.01% year over year. The core metric, the price-to-earnings ratio (PE), stands at 5.90 this period, down 55.05% year-on-year and 13.10% month-on-month. The core metric, the price-to-book ratio (PB), stands at 0.33 this period, down 49.66% year-on-year and up 8.97% quarter-on-quarter. Key indicator: Manufacturing PMI new orders stood at 50.50 this period, placing it at the 48th percentile over the past 10 years, up 1.61% year-on-year and down 0.20% month-on-month.
Full report and figures: download the original Chinese file.
(0950.HK) Lee’s Pharmaceutical’s current price is HK$1.20. The medium- to long-term price trend (weekly MA10) is bullish, with the weekly chart showing a volatile structure this period. The near-term price trend (daily MA10) is also bullish, and the daily chart is currently in an upward formation. The medium- to long-term price trend of the Hang Seng Index (weekly K-line MA10) is bearish. Strong operations, undervalued. The core metric of operating cash flow to net profit is 2.47 for the current period, down 10.01% year over year. The core metric, the price-to-earnings ratio (PE), stands at 5.90 this period, down 55.05% year-on-year and 13.10% month-on-month. The core metric, the price-to-book ratio (PB), stands at 0.33 this period, down 49.66% year-on-year and up 8.97% quarter-on-quarter. Key indicator: Manufacturing PMI new orders stood at 50.50 this period, placing it at the 48th percentile over the past 10 years, up 1.61% year-on-year and down 0.20% month-on-month.